Suzhou, China

Yuejun Gao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gfb (Abc), LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuejun Gao. Retrieved from https://idiyas.com/inventor/yuejun-gao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuejun Gao and a Crystalline Pyridazinone TRPC Inhibitor

Introduction

Yuejun Gao is an inventor associated with Suzhou, China. His patent work includes a disclosure concerning crystalline forms of a pyridazinone TRPC inhibitor.

Latest Patents

Gao is named on one patent, titled “Crystal Forms of a Pyridazinone TRPC Inhibitor.” The disclosure describes crystalline forms of Compound 100 and notes that certain forms have characteristic peaks in XRPD patterns illustrated in the patent’s figures. The supplied figure references are incomplete, so specific peak positions cannot be stated here. Gao’s record lists 1 patent.

Career Highlights

The available information associates Gao with Gfb (Abc), LLC. The patent disclosure reflects work on crystalline forms of a compound identified as a TRPC inhibitor.

Collaborations

Wenfeng Xue is identified as Gao’s coworker. The provided information does not specify their roles or the nature of their collaboration on the patent.

Conclusion

Yuejun Gao’s listed patent contribution concerns crystalline forms of a pyridazinone TRPC inhibitor, connecting his inventor profile in Suzhou with pharmaceutical compound research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…